Northwell Hematology and Medical Oncology

Topics

• Acute Myeloid Leukemia Research 134
• Chronic Lymphocytic Leukemia Research 94
• Cancer Immunotherapy and Biomarkers 69
• Ocular Oncology and Treatments 69
• Hematopoietic Stem Cell Transplantation 52
• Prostate Cancer Treatment and Research 42
• Lymphoma Diagnosis and Treatment 28
• Multiple Myeloma Research and Treatments 28
• Cutaneous Melanoma Detection and Management 26
• Pancreatic and Hepatic Oncology Research 24
• Cancer Genomics and Diagnostics 21
• Immunotherapy and Immune Responses 21

Most cited

1. Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.

   The New England journal of medicine · 2023 · 739 citations · Craig Devoe

2. Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.

   The New England journal of medicine · 2023 · 633 citations · Veena John

3. Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma.

   The New England journal of medicine · 2021 · 741 citations · Richard Carvajal

4. Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial.

   Nature medicine · 2024 · 227 citations · Craig Devoe

5. Advances in the clinical management of uveal melanoma.

   Nature reviews. Clinical oncology · 2023 · 233 citations · Richard Carvajal

6. Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.

   The New England journal of medicine · 2023 · 219 citations · Tony Philip

7. Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma.

   The New England journal of medicine · 2023 · 246 citations ·